Sector consensus Legend Biotech Corporation

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 06/03/2026 GMT			5-day change	1st Jan Change
18.97 ^USD	+6.87%		-0.16%	-12.74%

02-23	Gilead to buy cancer therapy developer Arcellx for up to $7.8 billion	RE
02-12	Legend Biotech Shares Lower After Rothschild & Co Redburn Downgrade	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
LEGEND BIOTECH CORPORATION			US$58.7	+209.42%	16
ARGENX SE			€835.07	+34.21%	15
WUXI APPTEC CO., LTD.			CN¥133.13	+42.69%	18
INSMED INCORPORATED			US$212.53	+51.66%	19
BIONTECH SE			US$118.29	+35.13%	19
WUXI BIOLOGICS (CAYMAN) INC.			HK$39.84	+24.81%	23
GENMAB A/S			DKK 2,229.91	+29.01%	14
AKESO, INC.			HK$153.88	+62.51%	21
SUMMIT THERAPEUTICS INC.			US$23.49	+107.73%	13
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.			HK$536.92	+39.03%	17
EXELIXIS, INC.			US$46.83	+12.73%	18
MADRIGAL PHARMACEUTICALS, INC.			US$667.57	+54.23%	14
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	₩770,000	+41.54%	1
IMMUNITYBIO, INC.			US$15.25	+75.89%	4
VAXCYTE, INC.			US$109	+83.84%	9
ARROWHEAD PHARMACEUTICALS, INC.			US$81.36	+36.01%	11
PHARMAESSENTIA CORPORATION			NT$753.19	+7.91%	7
NUVALENT, INC.			US$143.53	+44.38%	17
REMEGEN CO., LTD.			HK$86.68	+15.15%	15
Average			40,855.01	+53.05%	14
Weighted average by Cap.			24,204.99	+44.66%	16